Skip to content

XIENCE V 1009539-12Recalls & reported problems

Abbott Vascular Inc. · XIENCE V Everolimus Eluting Coronary Stent System 2.50 mm x 12 mm / Rapid-Exchange · Class 3 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08717648063794), received between Oct 19, 2016 and Oct 19, 2016 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Ischemia1
  • Stenosis1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 19, 2016Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT ON (B)(6) 2011, A 2.5X12MM XIENCE V STENT WAS SUCCESSFULLY IMPLANTED IN THE DISTAL LEFT ANTERIOR DESCENDING (LAD) CORONARY ARTERY LESION. ON (B)(6) 2013, THE PATIENT WAS ADMITTED TO THE HOSPITAL DUE TO SILENT ISCHEMIA AND RESTENOSIS OF THE DISTAL LAD STENT. ON (B)(6) 2013, PERCUTANEOUS INTERVENTION WAS PERFORMED AS TREATMENT. THE EVENT RESOLVED WITHOUT SEQUELA AND ON (B)(6) 2013, THE PATIENT WAS DISCHARGED FROM THE HOSPITAL. THERE WAS NO ADDITIONAL INFORMATION PROVIDED.

    Patient problems: Ischemia; Stenosis

    MAUDE report 6042438 ↗

Other Coronary drug-eluting stent devices

All Coronary drug-eluting stent devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page